Veterinary Sciences articles

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 118

Article ‘Count’ for Veterinary Sciences.

Journal Count
1
Self-Assembled Nanoparticle Vaccines Elicit Robust Protective Immune Responses against Type O Foot-and-Mouth Disease Virus Infection
4
Viral Capsid Protein Architecture Informed Selection of ssDNA Aptamers for Specific Detection of FMDV
Ultrasensitive Tracking of Dual Antiparasitics in Living Tissues: UPLC-MS/MS Reveals Synergistic Distribution of Oxyclozanide and Levamisole Hydrochloride
Dendritic Mesoporous UiO-66 as Nanoreactors for Dual-Mode Detection of the Rabies Virus Nucleoprotein Gene
Optimization of Extraction Methods for the Quantification of Proteins in Mammalian Tissues
1
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trial
2
Evolution of antibody cross-reactivity to influenza H5N1 neuraminidase from an N2-specific germline
Deep mutational scanning of rabies glycoprotein defines mutational constraint and antibody-escape mutations
1
Exploring RNA G-quadruplex in the rabies virus genome and its potential against RABV infection
1
Identification of and Response to Influenza A(H5) in Off-the-Shelf Raw Milk—Santa Clara County, California, November–December 2024
1
Isolation of an infectious mammalian chu-like virus from tumor cells of the endangered Tasmanian devil (Sarcophilus harrisii)
2
Structural Analogs TOCP and TPHP Induce Immunotoxicity in Zebrafish through Divergent Disruption of Energy Metabolism
TRPM2 mediates tire-derived pollutant 6PPD-Q-induced male reproductive impairment via autophagy in mice
2
Associations of paraben exposures measured by repeated urinary biomarkers with sperm DNA damage and apoptosis
Spatial extent and age-related bioaccumulation of fluoride in the bones of house sparrows around aluminium smelting operations
3
Alternative Vertebrate and Invertebrate Model Organisms Show Similar Sensitivity as Rodents to a Diverse Set of Chemicals
Composition, Antibiotic Resistance, and Functionality of the Gut Microbiome in Urban Cats
Detection of Hemagglutinin H5 Influenza A Virus RNA and Model of Potential Inputs in an Urban California Sewershed
1
Immunopathogenesis of lethal H5N1 avian influenza virus clade 2.3.4.4b infection in macaques
3
Effect of pH on small-molecule inhibitor binding to influenza virus hemagglutinin
Structural architecture of the human long non-coding RNA-PAAN, as a potential target for anti-influenza drug development
Newcastle disease virus exploits the phospholipid flippase ATP11c–CDC50A complex to promote viral infection
2
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active site
Hemodynamic forces prevent myxomatous valve disease in mice through KLF2/4 signaling
1
Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza
3
Machine learning-enabled quantification of hepatocellular necrosis in the liver after lethal Marburg and Ebola virus exposures
Avian influenza virus A(H5N1) genotype D1.1 is better adapted to human nasal and airway organoids than genotype B3.13
Highly Pathogenic Avian Influenza Virus A/H5N1 Subclade 2.3.4.4b Isolated from a European Grey Seal (Halichoerus grypus) Is Highly Virulent in Ferrets
2
Harnessing Multiplexed Proteolysis-Targeting Chimera for Comprehensive Influenza A Virus Targeting
Rabies Virus Targeting NIR-II Phototheranostics
1
Understanding Influenza A Virus Particles Detaching from Reconstructed Cell Surfaces
2
Ecology and spread of the North American H5N1 epizootic
A vaccine central in A(H5) influenza antigenic space confers broad immunity
37
Genomic analysis of high pathogenicity avian influenza viruses from Antarctica reveals multiple introductions from South America
Increased contact transmission of contemporary Human H5N1 compared to Bovine and Mountain Lion H5N1 in a hamster model
Mapping global avian influenza risk patterns through waterbird activity entropy
Potent efficacy of an NA-targeting antibody against a broad spectrum of H5N1 influenza viruses
A single mutation in nonstructural protein 1 is critical for the adaptive evolution of influenza B virus
Baloxavir outperforms oseltamivir, favipiravir, and amantadine in treating lethal influenza A(H5N1) HA clade 2.3.4.4b infection in mice
MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses
Assessing HPAI-H5 transmission risk across wild bird migratory flyways in the United States
Vaccination against H5 HP avian influenza virus leads to persistent immune response in wild king penguins
Advancing A(H5N1) influenza risk assessment in ferrets through comparative evaluation of airborne virus shedding patterns
IFITM3 deficiency drives SARS-CoV-2 adaptation while preserving variant-specific traits
Polymerase mutations underlie early adaptation of H5N1 influenza virus to dairy cattle and other mammals
Environmental metagenomics enhances detection of circulating viruses from live poultry markets in Cambodia
Multi-generational koala pedigree analysis reveals rapid changes in heritable provirus load associated with life history traits
Emergence of mammalian-adaptive PB2 mutations enhances polymerase activity and pathogenicity of cattle-derived H5N1 influenza A virus
The potential of H5N1 viruses to adapt to bovine cells varies throughout evolution
Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin
SARS-CoV-2 within-host population expansion, diversification and adaptation in zoo tigers, lions and hyenas
The E3 ubiquitin ligase FBXL18 stabilizes BST2 to promote inflammation in RABV-infected astrocytes
A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance
Host switching mutations in H5N1 influenza hemagglutinin suppress site-specific activation dynamics
Dominant substitutions underlying the antigenic evolution of H5 influenza virus
A prospective trial for breast cancer diagnosis by canine odorology
Characterization of two non-competing antibodies to influenza H3N2 hemagglutinin stem reveals its evolving antigenicity
Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protection
RNA replicon vaccination confers long-lasting protection against H5N1 avian influenza in 23 zoo bird species
Circumpolar spread of avian influenza H5N1 to southern Indian Ocean islands
Design and nonviral delivery of live attenuated vaccine to prevent chronic hepatitis C virus-like infection
Broad neuraminidase antibodies confer protection against seasonal and avian influenza viruses
Structural convergence and water-mediated substrate mimicry enable broad neuraminidase inhibition by human antibodies
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3
Genotype B3.13 influenza A(H5N1) viruses isolated from dairy cattle demonstrate high virulence in laboratory models, but retain avian virus-like properties
Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin–Matrix-M nanoparticle vaccine induces neutralizing responses in nonhuman primates
The impact of highly pathogenic avian influenza H5N1 virus infection on dairy cows
Highly pathogenic avian influenza H5N1 clade 2.3.4.4b genotype B3.13 is highly virulent for mice, rapidly causing acute pulmonary and neurologic disease
Efficacy of baloxavir marboxil against bovine H5N1 virus in mice
Surveillance of avian influenza through bird guano in remote regions of the global south to uncover transmission dynamics
3
Rapid expansion of genotype D1.1 A(H5N1) influenza viruses in wild birds across North America during the 2024 migratory season
H5N1 influenza virus stability and transmission risk in raw milk and cheese
Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025
1
Genetic diversity of H9N2 avian influenza viruses in poultry across China and implications for zoonotic transmission
3
Modeling of H5N1 influenza virus kinetics during dairy cattle infection suggests the timing of infectiousness
Mammalian antiviral proteins ZAP and KHNYN can independently restrict CpG-enriched avian viruses
Influenza A virus induces PI4P production at the endoplasmic reticulum in an ATG16L1-dependent manner to promote the egress of viral ribonucleoproteins.
2
Two genes, one culprit - a functional candidate validation of a SPATA7 deletion in dogs with day blindness/retinal degeneration
Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression
1
Safety and Efficacy of Plant-Produced Trivalent Virus-Like Particle Vaccine Candidate Against Bluetongue Disease
16
Efficient replication of influenza D virus in the human airway underscores zoonotic potential
Distinct evolutionary patterns of endemic and emerging parvoviruses and the origin of a new pandemic virus
Dermcidin has antiviral activity and protects against influenza
Small molecule–constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins
Oseltamivir aziridines are potent influenza neuraminidase inhibitors and imaging agents
A canine PLP1 missense variant differentiates oligodendrocyte maturation in connatal and classical Pelizaeus–Merzbacher disease
A SynB1-conjugated antibody cocktail crosses the blood–brain barrier to produce a therapeutic effect on rabies
Structural basis for a potent human neutralizing antibody targeting a conserved epitope on the H7 hemagglutinin head
Human MX1 orchestrates the cytoplasmic sequestration of neosynthesized influenza A virus vRNPs
Preferential apical infection and spread of human metapneumovirus highlights the importance of inhaled delivery of neutralizing monoclonal antibody to treat established infections
Enhanced visualization of influenza A virus entry into living cells using virus-view atomic force microscopy
ApoD mediates age-associated increase in vulnerability to influenza virus infection
Landscape changes elevate the risk of avian influenza virus diversification and emergence in the East Asian–Australasian Flyway
Mechanistic insights into the small-molecule inhibition of influenza A virus entry
A bacteria-based search for drugs against avian and swine flu yields a potent and resistance-resilient channel blocker
Genomic analyses identify 15 risk loci and reveal HDAC2, SOX2-OT, and IGF2BP2 in a naturally occurring canine model of gastric cancer
1
Sociality and kinship constrain the free-mixing of pathogens in a wild mammal host population
5
Polymerase trapping as the mechanism of H5 highly pathogenic avian influenza virus genesis
STING–NF-κB signaling builds an influenza spillover barrier
The oncogenome of the domestic cat
Avian-origin influenza A viruses tolerate elevated pyrexic temperatures in mammals
Molecular basis of influenza ribonucleoprotein complex assembly and processive RNA synthesis
8
Blood feeding triggers the terminal differentiation of precursor cells in tick salivary glands
Ecological vaccination: A strategy to prevent zoonotic spillover from bats
Regulatory hotspot on the influenza A virus polymerase revealed through the structure of the NEP-polymerase complex
Lightweight multiscale early warning system for influenza A spillovers
Repeated oral exposure to H5N1 influenza virus in pasteurized milk does not cause adverse responses to subsequent influenza infection
PB2 and NP of North American H5N1 virus drive immune cell replication and systemic infections
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations
Spatiotemporal reconstruction of the North American A(H5N1) outbreak reveals successive lineage replacements by descendant reassortants
5
Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice
Baloxavir alleviates severe disease and viremia in ferrets infected with avian- or bovine-origin influenza A(H5N1) virus
An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques
A replicating RNA vaccine protects cynomolgus macaques against lethal clade 2.3.4.4b influenza A H5N1 virus challenge
Preexisting immunity to the 2009 pandemic H1N1 virus reduces susceptibility to H5N1 infection and disease in ferrets
1
Tyrosine kinase targeting uncovers oncogenic pathway plasticity in Tasmanian devil transmissible cancers
1
Unique microbial communities and phylosymbiosis signals in herpetofauna
1
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trial

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.